Access Bio Inc (950130) — Capital Reinvestment Ratio
Access Bio Inc (950130) has a Capital Reinvestment Ratio of 0.12x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩5.35 Million) in capital expenditures (₩635.11K). Check Access Bio Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Access Bio Inc Capital Reinvestment Ratio (2012–2024)
This chart tracks Access Bio Inc's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Access Bio Inc cash conversion from operations.
Annual Capital Reinvestment Ratio for Access Bio Inc (2012–2024)
Year-by-year Capital Reinvestment Ratio for Access Bio Inc from 2012 to 2024. See 950130 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | ₩13.54 Million | ₩1.40 Million | ▲ +101.5% |
| 2022 | 0.05x | ₩291.33 Million | ₩14.90 Million | ▼ -75.5% |
| 2021 | 0.21x | ₩137.90 Million | ₩28.76 Million | ▼ -26.3% |
| 2020 | 0.28x | ₩36.72 Billion | ₩10.38 Billion | ▼ -94.0% |
| 2016 | 4.74x | ₩2.11 Million | ₩10.03 Million | ▲ +180.1% |
| 2015 | 1.69x | ₩2.87 Billion | ₩4.85 Billion | ▲ +2.0% |
| 2013 | 1.66x | ₩1.59 Billion | ₩2.63 Billion | ▲ +134.3% |
| 2012 | 0.71x | ₩1.85 Billion | ₩1.31 Billion | — |